NYSE American - Delayed Quote USD
BiomX Inc. (PHGE)
0.5160
-0.0411
(-7.38%)
At close: May 9 at 4:00:00 PM EDT
0.5212
+0.01
+(1.01%)
After hours: May 9 at 6:27:14 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 2 |
Avg. Estimate | -0.3 | -0.22 | -2.06 | -2.3 |
Low Estimate | -0.3 | -0.22 | -2.92 | -3.1 |
High Estimate | -0.3 | -0.22 | -1.19 | -1.5 |
Year Ago EPS | -2.8 | -1.06 | -3.36 | -2.06 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -1.15 | -0.87 | -0.4 | -1.1 |
EPS Actual | -2.8 | -1.06 | -0.67 | -2.31 |
Difference | -1.65 | -0.19 | -0.27 | -1.22 |
Surprise % | -143.48% | -22.31% | -66.76% | -110.97% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.3 | -0.22 | -2.06 | -2.3 |
7 Days Ago | 0 | 0 | -2.52 | -2.73 |
30 Days Ago | 0 | 0 | -2.52 | -2.73 |
60 Days Ago | 0 | 0 | -2.52 | -2.73 |
90 Days Ago | 0 | 0 | -2.52 | -2.73 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | -- | 1 |
Up Last 30 Days | 1 | 1 | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
PHGE | 89.29% | 79.25% | 38.90% | -11.92% |
S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 4/4/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 1/8/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/16/2024 |
Initiated | Laidlaw & Co.: Buy | 5/28/2024 |
Related Tickers
ARMP Armata Pharmaceuticals, Inc.
1.2900
-5.15%
LIANY LianBio
0.2000
+8.99%
SPPH Spencer Pharmaceutical Inc.
0.0001
0.00%
APTOF Aptose Biosciences Inc.
1.6500
0.00%
INVA Innoviva, Inc.
18.56
-0.11%
CLRPF Clarity Pharmaceuticals Ltd
1.5500
0.00%
EVGN Evogene Ltd.
1.1325
+0.22%
CLGN CollPlant Biotechnologies Ltd.
1.8200
-0.55%
NAVB Navidea Biopharmaceuticals, Inc.
0.0006
0.00%
MTEM Molecular Templates, Inc.
0.0001
0.00%